The 'Surprisingly Soft' Unit That Caused Danaher To Plummet
Danaher shares slide despite second-quarter earnings and revenue beats, driven by softness in its biotech unit.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Where it stands
Danaher reported second-quarter earnings and revenue that beat expectations and raised its profit forecast. However, the company cut its revenue outlook due to a miss in its biotech unit, which Investor's Business Daily described as "surprisingly soft." Coverage from Yahoo Finance, Seeking Alpha, and 10TV emphasizes the disconnect between the quarterly earnings beat and the resulting stock price decline.
KELO-AM notes that the biotech miss overshadowed the positive profit forecast raise. Market attention remains on the company's revised revenue outlook and the performance of the biotech segment following the Q2 earnings snapshot.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 45d ago.
The reporting (13)
- Danaher (NYSE:DHR) Returns To Value Stock Focus After Results Update Kalkine Media · 45d ago
- Danaher’s revenue outlook cut, biotech miss overshadow profit forecast raise 1470 & 100.3 WMBD · 45d ago
- Danaher Corporation Provides Revenue Guidance for the Third Quarter 2026 marketscreener.com · 45d ago
- Danaher (DHR) Set to Report Q2 Earnings with Positive Expectatio GuruFocus · 45d ago
- Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session Benzinga · 45d ago
- Danaher (DHR) Q2 Earnings and Revenues Top Estimates Yahoo Finance · 45d ago
- Danaher Earnings Beat Estimates. Why the Stock Is Dropping Most Since 1991. Barron's · 45d ago
- Why Danaher Stock Just Tanked 14% Benzinga · 45d ago
- Danaher’s revenue outlook cut, biotech miss overshadow profit forecast raise KELO-AM · 45d ago
- Danaher: Q2 Earnings Snapshot 10TV · 45d ago
- Danaher stock slips despite Q2 earnings beat, raised guidance (DHR:NYSE) Seeking Alpha · 45d ago
- Danaher shares slide despite second-quarter earnings and revenue beat (DHR) Yahoo Finance · 45d ago
- The 'Surprisingly Soft' Unit That Caused Danaher To Plummet Investor's Business Daily · 45d ago broke it first
Answered
How did Danaher perform in Q2?
The company reported an earnings and revenue beat for the second quarter.
Why did the stock price decline?
Shares slid after Danaher cut its revenue outlook and reported a miss in its biotech unit.
Did Danaher change its profit guidance?
Yes, the company raised its profit forecast.
People, places & organizations
Topics
Related trends
The Surprising Reason This Biotech Plummeted 69%
EyePoint Pharmaceuticals shares cratered following a late-stage trial setback for its flagship eye disease drug.
FDA staff flags data concerns about Capricor's therapy; shares plunge
Capricor Therapeutics shares are plummeting after FDA staff disputed the company's claims of Phase 3 success for its DMD cell therapy.
Why another shocking Meta capex number may keep the stock underwater
Meta stock has fallen for seven consecutive days as investors weigh concerns over high capital expenditures ahead of the upcoming Q2 earnings report.
Tesla’s Revenue Beat Hid The Number That Actually Sank The Stock
Tesla’s earnings beat hides cash‑burn shock that drove its stock 15% lower
Intel Forecast Shatters Estimates, Fueled by Data Center Growth
Intel shares are climbing as the chipmaker reports its fastest revenue growth in nearly 15 years, driven by a surge in data center demand.
Charles Schwab Earnings: Why Stock Is Falling Despite Faster Growth
Charles Schwab stock declines following second-quarter earnings reports, despite the firm exceeding Wall Street expectations for revenue and growth.